BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6189580)

  • 1. Acid phosphatase in prostatic tissue homogenates from patients with benign prostatic hyperplasia and prostatic carcinoma.
    Copland GT; Whitehurst GB; Pretlow TP; Boohaker EA; Bartolucci AA; Pretlow TG
    Cancer; 1983 Jul; 52(1):155-60. PubMed ID: 6189580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow acid phosphatase by radioimmunoassay.
    Belville WD; Cox HD; Mahan DE; Olmert JP; Mittemeyer BT; Bruce AW
    Cancer; 1978 Jun; 41(6):2286-91. PubMed ID: 77719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid phosphatase content of prostatic exprimate from patients with advanced prostatic carcinoma: a potential prognostic and therapeutic index.
    Kent JR; Hill M; Bischoff A
    Cancer; 1970 Apr; 25(4):858-62. PubMed ID: 4191902
    [No Abstract]   [Full Text] [Related]  

  • 4. A radioimmune assay for human prostatic acid phosphatase-levels in prostatic disease.
    Mahan DE; Doctor BP
    Clin Biochem; 1979 Feb; 12(1):10-7. PubMed ID: 87287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ratio of serum tartrate-inhibitable acid phosphatase to total serum protein in benign prostatic hypertrophy and prostatic carcinoma.
    Petrovich G; Ursich-Jankovich J; Prijovich Z
    Clin Chem; 1992 Feb; 38(2):276-7. PubMed ID: 1371723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of serum prostatic acid phosphatase levels after prostatic massage.
    Wadström J; Huber P; Rutishauser G
    Urology; 1984 Dec; 24(6):550-1. PubMed ID: 6209846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of prostatic acid phosphatase assays.
    Wise WS; Kandaswamy K
    Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
    Salo JO; Rannikko S; Haapiainen R
    Br J Urol; 1990 Aug; 66(2):188-92. PubMed ID: 1697205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue acid and alkaline phosphatase in prostatic carcinoma.
    Erkan I; Remzi D; Ciliv G
    J Surg Oncol; 1980; 13(4):341-5. PubMed ID: 6154841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5'-nucleotidase activity in prostatic carcinoma and benign prostatic hyperplasia.
    Rackley RR; Lewis TJ; Preston EM; Delmoro CM; Bradley EL; Resnick MI; Pretlow TP; Pretlow TG
    Cancer Res; 1989 Jul; 49(13):3702-7. PubMed ID: 2471588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of rectal examination on serum acid phosphatase levels in benign and malignant prostatic disease.
    Osegbe DN; Magoha G
    Postgrad Med J; 1982 Dec; 58(686):763-6. PubMed ID: 6189110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme markers in human prostatic carcinoma.
    Chu TM; Wang MC; Kuciel R; Valenzuela L; Murphy GP
    Cancer Treat Rep; 1977; 61(2):193-200. PubMed ID: 68822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histochemical characterization of different tissue enzymes in prostate adenomas and carcinomas].
    Hajek J; Papousek F; Nemecek R; Hanselova M; Strmiska M
    Acta Urol Belg; 1985; 53(1):96-100. PubMed ID: 2581425
    [No Abstract]   [Full Text] [Related]  

  • 14. Counterimmunoelectrophoretic studies of serum prostatic acid phosphatase.
    Romas NA; Hsu KC; Ng PY; Pitts M; Tomashefsky P; Tannenbaum M
    Prostate; 1980; 1(4):451-6. PubMed ID: 6169076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of serum prostatic acid phosphatase assay based on the immunoenzymatic method (TZR-516)].
    Ikemoto I; Machida T; Oishi Y; Onishi T; Shirai T; Imanaka K
    Hinyokika Kiyo; 1989 Sep; 35(9):1639-42. PubMed ID: 2479240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic acid phosphatase in serum and bone marrow in patients with prostatic carcinoma.
    Fossà SD; Skinningsrud A; Kaalhus O; Engeset A
    Br J Urol; 1983 Jun; 55(3):306-11. PubMed ID: 6850249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme immunoassay of prostatic acid phosphatase after prostatic examination. Correlation with prostate size and immunopathology.
    el-Shirbiny AM; Shridhar P; al Adnani MS; Suresh LK
    Urology; 1988 Nov; 32(5):469-73. PubMed ID: 2460989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma.
    Debruyne FM; van Munster PJ; van Groeninghen JC; Kirkels WJ
    Urol Res; 1984; 12(5):233-7. PubMed ID: 6083652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian and day-to-day variation of prostatic acid phosphatase.
    Nissenkorn I; Mickey DD; Miller DB; Soloway MS
    J Urol; 1982 Jun; 127(6):1122-4. PubMed ID: 6177878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the leucine aminopeptidase activity in extracts from human prostatic carcinoma and benign prostatic hyperplasia.
    Rackley RR; Yang B; Pretlow TG; Abdul-Karim FW; Lewis TJ; McNamara N; Delmoro CM; Bradley EL; Kursh E; Resnick MI
    Cancer; 1991 Aug; 68(3):587-93. PubMed ID: 1712242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.